Paper Details

  1. Home
  2. Paper Details

Pivmecillinam plus pivampicillin in urinary tract infections. A double-blind comparison with pivmecillinam alone in hospitalized patients.

Author: SaltvedtE P, SchøyenR

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Pivmecillinam/pivampicillin had a higher bacteriological cure rate (82%) for uncomplicated urinary tract infections than pivmecillinam alone (72%). Both treatments were well tolerated and effective against Enterobacteriaceae.
Paper Details　
Original Abstract of the Article :
Forty hospitalized patients with mostly uncomplicated urinary tract infections received treatment for ten days with either pivmecillinam/pivampicillin of pivmecillinam alone. The bacteriological cure rate immediately after therapy was discontinued was 82% (18/22) in the combination group and 72% (13...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF01640832

データ提供：米国国立医学図書館（NLM）

Pivmecillinam Plus Pivampicillin for Urinary Tract Infections: A Double-Blind Comparison

Urinary tract infections (UTIs) are a common medical condition, especially among women. This double-blind study investigates the effectiveness of a combination therapy using pivmecillinam and pivampicillin compared to pivmecillinam alone in hospitalized patients with UTIs.

Combination Therapy Shows Promise for UTI Treatment

The study found that the combination therapy of pivmecillinam and pivampicillin achieved a higher bacteriological cure rate compared to pivmecillinam alone. The study also observed that the vast majority of UTIs were caused by Enterobacteriaceae, which were sensitive to mecillinam in vitro.

Navigating the Desert of UTI Symptoms

This study offers a potentially effective treatment option for UTIs, providing relief from the discomfort and complications associated with this common condition. It's like finding a reliable path through the arid landscape of UTI symptoms, offering a clear route to recovery.

Dr.Camel's Conclusion

This research highlights the importance of exploring different treatment strategies for UTIs to ensure optimal outcomes. Just as a camel relies on its knowledge of the desert to find the best route, we must seek the guidance of healthcare professionals to find the most effective treatment for our individual needs.
Date :
  1. Date Completed 1982-06-14
  2. Date Revised 2019-08-29
Further Info :

Pubmed ID

6279521

DOI: Digital Object Identifier

10.1007/BF01640832

Related Literature

Article Analysis
・Side Effects of pivmecillinam
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.